Form 8-K Oscar Health, Inc. For: Sep 16

Go back to Form 8-K Oscar Health, Inc. For: Sep 16

Oscar Health Inc (OSCR) PT Raised to $48 at Piper Sandler

September 17, 2026 7:20 AM EDT

Piper Sandler analyst Jessica Tassan raised the price target on Oscar Health Inc (NYSE: OSCR) to $48.00 while maintaining a Overweight rating.

The analyst comments "We introduce CY28-CY30 estimates and raise our PT to $48 based on a 12x multiple of CY30 adjusted... More